GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » Philip Morris International Inc (NYSE:PM) » Definitions » 5-Year EBITDA Growth Rate
中文

Philip Morris International (Philip Morris International) 5-Year EBITDA Growth Rate : 2.60% (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Philip Morris International 5-Year EBITDA Growth Rate?

Philip Morris International's EBITDA per Share for the three months ended in Dec. 2023 was $2.15.

During the past 12 months, Philip Morris International's average EBITDA Per Share Growth Rate was -0.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 2.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 0.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Philip Morris International was 16.00% per year. The lowest was -5.50% per year. And the median was 3.60% per year.


Competitive Comparison of Philip Morris International's 5-Year EBITDA Growth Rate

For the Tobacco subindustry, Philip Morris International's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Philip Morris International's 5-Year EBITDA Growth Rate Distribution in the Tobacco Products Industry

For the Tobacco Products industry and Consumer Defensive sector, Philip Morris International's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Philip Morris International's 5-Year EBITDA Growth Rate falls into.



Philip Morris International 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Philip Morris International  (NYSE:PM) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Philip Morris International 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Philip Morris International's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Philip Morris International (Philip Morris International) Business Description

Address
677 Washington Boulevard, Suite 1100, Stamford, Connecticut, New York, NY, USA, 06901
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from cigarettes with the 2022 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches, primarily in the U.S. and Scandinavia. It diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Executives
Wilde Frederic De officer: Sr. VP, Marketing & Sales 120 PARK AVENUE, NEW YORK NY 10017
Yann Guerin officer: SVP & Global Head of L&C 677 WASHINGTON BLVD., SUITE 1100, STAMFORD CT 06901
Werner Barth officer: Sr. VP, Marketing and Sales 120 PARK AVENUE, NEW YORK NY 10017
Lars Dahlgren officer: Pres. Smoke-Free Oral Products 677 WASHINGTON BLVD., STAMFORD CT 06896
Dessislava Temperley director C/O CIMPRESS PLC, 275 WYMAN STREET, WALTHAM MA 02451
Reginaldo Dobrowolski officer: Vice President and Controller 677 WASHINGTON BLVD, SUITE 1100, STAMFORD CT 06901
Martin G. King officer: SVP Operations 120 PARK AVENUE, NEW YORK NY 10017
Paul Riley officer: Pres East Asia & Australia 120 PARK AVENUE, NEW YORK NY 10017
Drago Azinovic officer: Pres., European Union Region 120 PARK AVENUE, NEW YORK NY 10017
Mario Masseroli officer: Pres., Latin America & Canada 120 PARK AVENUE, NEW YORK NY 10017
Juan J. Daboub director 5100 W. 115TH PLACE, LEAWOOD KS 66211
Shlomo Yanai director ONE MEADOWLANDS PLAZA, EAST RUTHERFORD NJ 07073
Stacey Kennedy officer: Pres. South & Southeast Asia 120 PARK AVENUE, NEW YORK NY 10017
Charles Bendotti officer: Senior VP, Human Resources 120 PARK AVENUE, NEW YORK NY 10017
Andre Calantzopoulos director, officer: President & CEO 677 WASHINGTON BLVD, SUITE 1100, STAMFORD CT 06901